Plasma GFAP was a significant partial mediator of both the relationship between amyloid‐PET and tau‐PET as well as amyloid‐PET and pTau‐217, suggesting that astrogliosis is a key step in AD development in DS. The gene discussed is MAPT; the disease is Dravet syndrome.